{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:10:37Z","timestamp":1691493037786},"reference-count":28,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug and Chemical Toxicology"],"published-print":{"date-parts":[[2023,9,3]]},"DOI":"10.1080\/01480545.2022.2104866","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:02:55Z","timestamp":1659520975000},"page":"841-850","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Acute, repeated inhalation toxicity, respiratory system irritation, and mutagenicity studies of 1,1,2,2-tetrafluoroethane (HFC-134) as the impurity in the pharmaceutical propellant 1,1,1,2-tetrafluoroethane (HFA-134a)"],"prefix":"10.1080","volume":"46","author":[{"given":"Yanjun","family":"Zhao","sequence":"first","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China"},{"name":"National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Sun","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China"},{"name":"National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China"},{"name":"National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Yang","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China"},{"name":"National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1177\/096032719501400903"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(94)90307-7"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050478"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1996.0092"},{"key":"CIT0005","volume-title":"Pharmacopoeia of the People's Republic of China (ChP)","author":"Chinese Pharmacopeia","year":"2020"},{"key":"CIT0006","volume-title":"Joint Assessment of Commodity Chemicals No. 14 1-chloro-2,2,2,-trifluoroethane (HFA-133a). CAS:75-88-7.","author":"[ECETOC] European Center for Ecotoxicology and Toxicology of Chemicals","year":"1990"},{"key":"CIT0007","volume-title":"Joint Assessment of Commodity Chemicals No. 50 1,1,1,2-tetrafluoroethane (HFC-134a). CAS:75-88-7.","author":"[ECETOC] European Center for Ecotoxicology and Toxicology of Chemicals","year":"2006","edition":"2"},{"key":"CIT0008","volume-title":"European Pharmacopeia.","author":"[EP] European Pharmacopeia","year":"2016","edition":"9"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/30.7.280"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1995.1163"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(83)90010-9"},{"key":"CIT0012","volume-title":"Guidance for single dose acute toxicity testing for pharmaceuticals","author":"[NMPA] National Medical Products Administration","year":"2014"},{"key":"CIT0013","volume-title":"Guidance for irritation, sensitization and hemolysis testing of drug products","author":"[NMPA] National Medical Products Administration","year":"2014"},{"key":"CIT0014","volume-title":"Guideline for repeated dose toxicity of drug products","author":"[NMPA] National Medical Products Administration","year":"2014"},{"key":"CIT0015","volume-title":"Acute exposure guideline levels for selected airborne chemicals","volume":"2","author":"[NRC] National Research Council","year":"2002"},{"key":"CIT0016","volume-title":"Test no. 403: acute inhalation toxicity, OECD guidelines for the testing of chemicals, section 4","author":"[OECD] Organization for Economic Cooperation and Development","year":"2009"},{"key":"CIT0017","volume-title":"Test no. 412: subacute inhalation toxicity: 28-day study, section 4","author":"[OECD] Organization for Economic Cooperation and Development","year":"2018"},{"key":"CIT0018","volume-title":"Test no. 471: bacterial reverse mutation test, section 4","author":"[OECD] Organization for Economic Cooperation and Development","year":"2020"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-813X(01)00011-0"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/52.2.289"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3109\/01480545.2012.661738"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2016.1297"},{"key":"CIT0023","volume-title":"The Montreal Protocol on substances that deplete the ozone layer","author":"The Kigali Amendment","year":"2016"},{"key":"CIT0024","volume-title":"USP41-NF36 S1","author":"[USP] The United States Pharmacopeia","year":"2018"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310386499"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.3109\/01480545.2012.749273"},{"key":"CIT0027","volume-title":"Metered dose inhaler (MDI) and dry powder inhaler (DPI) products-quality considerations guidance for industry (DRAFT GUIDANCE)","author":"[CDER] U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research","year":"2018"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1177\/0748233719825528"}],"container-title":["Drug and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01480545.2022.2104866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T10:35:11Z","timestamp":1691490911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01480545.2022.2104866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9,3]]}},"alternative-id":["10.1080\/01480545.2022.2104866"],"URL":"https:\/\/doi.org\/10.1080\/01480545.2022.2104866","relation":{},"ISSN":["0148-0545","1525-6014"],"issn-type":[{"value":"0148-0545","type":"print"},{"value":"1525-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idct20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idct20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}